Signal active
Organization
Contact Information
Overview
uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access to regulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams
About
Information Technology, Software, Life Science, Health Care, Medical, mHealth
2017
51-100
Headquarters locations
Europe
Social
N/A
Profile Resume
Umedeor headquartered in Europe, operates in the Information Technology, Software, Life Science, Health Care, Medical, mHealth sector. The company focuses on Information Technology and has secured $2.2B in funding across 120 round(s). With a team of 51-100 employees, Umedeor is actively contributing to advancements in Information Technology. Their latest funding round, Series A - Umedeor, raised $12.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
5
4
0
$18.4M
Details
4
Umedeor has raised a total of $18.4M in funding over 4 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2018 | Seed | 450.0K | ||
2019 | Seed | 650.0K | ||
2020 | Seed | 4.8M | ||
2023 | Early Stage Venture | 12.5M |
Investors
Umedeor is funded by 24 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Rosie Barnett | - | FUNDING ROUND - Rosie Barnett | 12.5M |
Chris Smith | - | FUNDING ROUND - Chris Smith | 12.5M |
Umedeor | - | FUNDING ROUND - Umedeor | 12.5M |
Playfair Capital | - | FUNDING ROUND - Playfair Capital | 12.5M |
Recent Activity
There is no recent news or activity for this profile.